Scotland · NHS Scotland MSAN
Admelog® (insulin lispro) 100units/ml solution for injection 3ml cartridges
MSAN(2025)43 · Level 2 · issued 22 Sep 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| vials are being discontinued with supplies anticipated to be exhausted by mid-March 2026, late | Discontinued | — |
| remain available and can support increased demand. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and organisations | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2025:43
- Recorded
- 06 Aug 2026 21:25 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 06 Aug 2026 21:25 UTC
- Content hash
b6a6af3b9161591465e850002a918ec92a554898d12bb86015252b849e443a6esha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2025-43.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.